Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CSTL NASDAQ:DCGO NASDAQ:FLGT NASDAQ:INNV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCSTLCastle Biosciences$19.66-0.9%$18.00$15.45▼$35.84$567.62M1.1422,211 shs284,050 shsDCGODocGo$1.49-0.7%$1.57$1.23▼$5.68$151.95M0.97759,684 shs822,394 shsFLGTFulgent Genetics$19.27-1.4%$20.20$14.57▼$25.11$586.66M1.03288,059 shs203,031 shsINNVInnovAge$4.14-1.4%$3.92$2.60▼$6.69$558.95M0.5151,052 shs128,742 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCSTLCastle Biosciences-0.91%-3.08%+6.62%-0.20%+12.47%DCGODocGo-0.67%-5.99%-2.61%-37.66%-47.54%FLGTFulgent Genetics-1.43%-3.94%-11.28%+1.42%-1.68%INNVInnovAge-1.43%-6.55%+8.66%+46.81%-17.37%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCSTLCastle Biosciences2.3445 of 5 stars3.52.00.00.02.62.50.0DCGODocGo2.2121 of 5 stars3.31.00.00.02.72.50.6FLGTFulgent Genetics3.5829 of 5 stars2.31.00.04.12.93.30.6INNVInnovAge1.0088 of 5 stars1.82.00.00.02.21.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCSTLCastle Biosciences 3.00Buy$37.0088.20% UpsideDCGODocGo 2.50Moderate Buy$3.56138.93% UpsideFLGTFulgent Genetics 2.50Moderate Buy$24.0024.55% UpsideINNVInnovAge 1.50Reduce$5.0020.77% UpsideCurrent Analyst Ratings BreakdownLatest DCGO, FLGT, INNV, and CSTL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025CSTLCastle BiosciencesScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$44.00 ➝ $40.005/12/2025DCGODocGoCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold$5.00 ➝ $1.455/9/2025DCGODocGoNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$4.00 ➝ $3.005/9/2025DCGODocGoBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral5/6/2025FLGTFulgent GeneticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$16.00 ➝ $23.005/6/2025CSTLCastle BiosciencesLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $35.005/6/2025CSTLCastle BiosciencesCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$42.00 ➝ $37.005/5/2025FLGTFulgent GeneticsRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$24.00 ➝ $25.00(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCSTLCastle Biosciences$332.07M1.71$0.98 per share19.98$16.28 per share1.21DCGODocGo$616.55M0.25$0.42 per share3.52$3.09 per share0.48FLGTFulgent Genetics$283.47M2.07N/AN/A$36.92 per share0.52INNVInnovAge$763.85M0.73N/AN/A$2.04 per share2.03Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCSTLCastle Biosciences$18.25M-$0.1938.55N/AN/A-1.46%3.41%2.95%8/4/2025 (Estimated)DCGODocGo$19.99M-$0.0224.8318.63N/A-0.12%2.52%1.70%8/6/2025 (Estimated)FLGTFulgent Genetics-$42.71M-$1.330.00N/AN/A-13.94%-2.19%-2.02%8/1/2025 (Estimated)INNVInnovAge-$21.34M-$0.230.0069.00N/A-3.75%-11.91%-5.85%9/9/2025 (Estimated)Latest DCGO, FLGT, INNV, and CSTL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025DCGODocGo-$0.06N/AN/AN/A$77.58 millionN/A8/4/2025Q2 2025CSTLCastle Biosciences-$0.44N/AN/AN/A$71.53 millionN/A8/1/2025Q2 2025FLGTFulgent Genetics-$0.23N/AN/AN/A$76.21 millionN/A5/8/2025Q1 2025DCGODocGo-$0.01-$0.09-$0.08-$0.09$104.25 million$96.03 million5/6/2025Q3 2025INNVInnovAge-$0.02-$0.08-$0.06-$0.08$214.09 million$218.14 million5/5/2025Q1 2025CSTLCastle Biosciences-$0.08-$0.20-$0.12-$0.90$80.40 million$87.99 million5/2/2025Q1 2025FLGTFulgent Genetics-$0.18$0.04+$0.22-$0.37$71.26 million$73.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCSTLCastle BiosciencesN/AN/AN/AN/AN/ADCGODocGoN/AN/AN/AN/AN/AFLGTFulgent GeneticsN/AN/AN/AN/AN/AINNVInnovAgeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCSTLCastle Biosciences0.029.379.19DCGODocGoN/A2.442.44FLGTFulgent GeneticsN/A6.326.32INNVInnovAge0.040.780.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCSTLCastle Biosciences92.60%DCGODocGo56.44%FLGTFulgent Genetics48.06%INNVInnovAge12.26%Insider OwnershipCompanyInsider OwnershipCSTLCastle Biosciences6.50%DCGODocGo2.70%FLGTFulgent Genetics31.76%INNVInnovAge1.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCSTLCastle Biosciences54028.87 million27.00 millionOptionableDCGODocGo4,407101.98 million99.23 millionOptionableFLGTFulgent Genetics1,31330.44 million20.78 millionOptionableINNVInnovAge2,350135.01 million133.12 millionOptionableDCGO, FLGT, INNV, and CSTL HeadlinesRecent News About These CompaniesInnovAge (NASDAQ:INNV) Stock Price Down 5.1% - Should You Sell?July 11 at 1:52 PM | marketbeat.comInnovAge (NASDAQ:INNV) Shares Gap Down - Should You Sell?July 7, 2025 | marketbeat.comInnovAge (NASDAQ:INNV) Trading 5.1% Higher - What's Next?July 3, 2025 | americanbankingnews.comInnovAge (NASDAQ:INNV) Trading Up 5.1% - Here's WhyJuly 3, 2025 | marketbeat.comEarnings Forecast & History for InnovAge Holding Corp (INNV) | Price ReactionsJune 29, 2025 | investing.comInnovAge (NASDAQ:INNV) Shares Down 4.2% - Should You Sell?June 25, 2025 | marketbeat.comInnovAge Agrees To $27 Million Settlement For ‘Misleading’ Statements In Its IPOJune 23, 2025 | homehealthcarenews.comHInsider Buying: InnovAge Holding Corp. (NASDAQ:INNV) Director Buys 8,450 Shares of StockMay 31, 2025 | insidertrades.comInsider Buying: InnovAge Holding Corp. (NASDAQ:INNV) COO Buys 10,000 Shares of StockMay 14, 2025 | insidertrades.comInnovAge Reports Mixed Earnings with Strong GrowthMay 12, 2025 | tipranks.comInnovAge Holding Corp. (INNV) Q3 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comInnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025May 6, 2025 | globenewswire.comInnovAge Holding Corp. to Announce Fiscal Q3 2025 Financial Results and Host Conference Call on May 6April 22, 2025 | quiverquant.comQInnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025April 22, 2025 | globenewswire.comWall Street Set to Open Mixed Thursday as Investors Parse Key Employment, Manufacturing DataApril 17, 2025 | msn.comInnovAge Champions PACE at State Capitols to Protect Critical Care for SeniorsApril 17, 2025 | globenewswire.comInnovAge Announces Participation at the KeyBanc Capital Markets Healthcare ForumMarch 4, 2025 | globenewswire.comInnovAge Reports Mixed Sentiment in Latest Earnings CallFebruary 5, 2025 | tipranks.comInnovAge reaffirms FY2025 guidance with revenue projected between $815M and $865MFebruary 5, 2025 | msn.comInnovAge Holding Corp. (INNV) Q2 2025 Earnings Call TranscriptFebruary 4, 2025 | seekingalpha.comInnovAge Holding Corp. Reports Q2 2025 Financial ResultsFebruary 4, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDCGO, FLGT, INNV, and CSTL Company DescriptionsCastle Biosciences NASDAQ:CSTL$19.66 -0.18 (-0.91%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$19.66 +0.00 (+0.03%) As of 07/11/2025 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.DocGo NASDAQ:DCGO$1.49 -0.01 (-0.67%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.48 -0.01 (-0.67%) As of 07/11/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Fulgent Genetics NASDAQ:FLGT$19.27 -0.28 (-1.43%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$19.28 +0.02 (+0.08%) As of 07/11/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.InnovAge NASDAQ:INNV$4.14 -0.06 (-1.43%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$4.11 -0.03 (-0.72%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
